Pharmaceutical Nanotechnology Laboratories

Ms Hajir Ali

PhD student

Hajir Ali

Nanofibrous peptide hydrogel for localised delivery of siRNA-loaded lipid nanoparticles targeting glioblastoma stem cells

Persistent STAT3 activation supports the survival and treatment resistance of residual glioma stem cells, contributing to glioblastoma recurrence. We are testing whether localised delivery of siRNA-loaded lipid nanoparticles from a peptide hydrogel can silence it.

Joined
2025
Supervisor
Dr Mohamed Elsawy
Co-supervisors
Dr Christos Tapeinos